![Craig Paterson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Craig Paterson
Nessuna posizione attualmente
Patrimonio netto: 404 340 $ in data 31/05/2024
Storia della carriera di Craig Paterson
Precedenti posizioni note di Craig Paterson
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALLAKOS INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2021 | 09/02/2024 |
UMass Chan Medical School | Corporate Officer/Principal | - | - |
Vivelix Pharmaceuticalsc Corp. | Direttore Tecnico/Scientifico/R&S | - | - |
Fondatore | - | - | |
ENDO INTERNATIONAL PLC | Direttore Tecnico/Scientifico/R&S | 08/09/2015 | - |
SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | - | - |
Formazione di Craig Paterson
McMaster University | Graduate Degree |
University of Tennessee | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Irlanda | 2 |
Canada | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ALLAKOS INC. | Health Technology |
Aziende private | 3 |
---|---|
Salix Pharmaceuticals Ltd.
![]() Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Endo International Plc
![]() Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Vivelix Pharmaceuticalsc Corp. |
- Borsa valori
- Insiders
- Craig Paterson
- Esperienza